These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 33160411)
1. LncRNA STXBP5-AS1 suppresses stem cell-like properties of pancreatic cancer by epigenetically inhibiting neighboring androglobin gene expression. Chen S; Huang L; Li G; Qiu F; Wang Y; Yang C; Pan J; Wu Z; Chen J; Tian Y Clin Epigenetics; 2020 Nov; 12(1):168. PubMed ID: 33160411 [TBL] [Abstract][Full Text] [Related]
2. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4. Hui B; Ji H; Xu Y; Wang J; Ma Z; Zhang C; Wang K; Zhou Y Cell Death Dis; 2019 Feb; 10(3):207. PubMed ID: 30814490 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression. Yan J; Jia Y; Chen H; Chen W; Zhou X J Exp Clin Cancer Res; 2019 Sep; 38(1):390. PubMed ID: 31488171 [TBL] [Abstract][Full Text] [Related]
4. Aberrant hypermethylation induced downregulation of antisense lncRNA STXBP5-AS1 and its sense gene STXBP5 correlate with tumorigenesis of glioma. Wang J; Yang L; Li Y; Wang XB; Yang W; Liu F; Wu XB Life Sci; 2021 Aug; 278():119590. PubMed ID: 33965377 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression. Yin D; Lu X; Su J; He X; De W; Yang J; Li W; Han L; Zhang E Mol Cancer; 2018 May; 17(1):92. PubMed ID: 29793547 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2. Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524 [TBL] [Abstract][Full Text] [Related]
7. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7. Gao J; Dai C; Yu X; Yin XB; Zhou F Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558 [TBL] [Abstract][Full Text] [Related]
8. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis. Zhang H; Zhu C; He Z; Chen S; Li L; Sun C J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166 [TBL] [Abstract][Full Text] [Related]
10. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells. Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672 [TBL] [Abstract][Full Text] [Related]
11. Loss of long noncoding RNA FOXF1-AS1 regulates epithelial-mesenchymal transition, stemness and metastasis of non-small cell lung cancer cells. Miao L; Huang Z; Zengli Z; Li H; Chen Q; Yao C; Cai H; Xiao Y; Xia H; Wang Y Oncotarget; 2016 Oct; 7(42):68339-68349. PubMed ID: 27577075 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA HOXB13-AS1 regulates HOXB13 gene methylation by interacting with EZH2 in glioma. Xiong Y; Kuang W; Lu S; Guo H; Wu M; Ye M; Wu L Cancer Med; 2018 Sep; 7(9):4718-4728. PubMed ID: 30105866 [TBL] [Abstract][Full Text] [Related]
13. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition. Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486 [TBL] [Abstract][Full Text] [Related]
14. Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription. Liu S; Zheng Y; Zhang Y; Zhang J; Xie F; Guo S; Gu J; Yang J; Zheng P; Lai J; Yin L; Wang H Theranostics; 2020; 10(23):10634-10651. PubMed ID: 32929371 [No Abstract] [Full Text] [Related]
15. The EZH2-PHACTR2-AS1-Ribosome Axis induces Genomic Instability and Promotes Growth and Metastasis in Breast Cancer. Chu W; Zhang X; Qi L; Fu Y; Wang P; Zhao W; Du J; Zhang J; Zhan J; Wang Y; Zhu WG; Yu Y; Zhang H Cancer Res; 2020 Jul; 80(13):2737-2750. PubMed ID: 32312833 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA. Qiu BQ; Lin XH; Ye XD; Huang W; Pei X; Xiong D; Long X; Zhu SQ; Lu F; Lin K; Zhang XQ; Xu JJ; Sheng LL; Zhang XM; Zhang PF; Wu YB Aging (Albany NY); 2020 Jan; 12(2):1843-1856. PubMed ID: 32005028 [TBL] [Abstract][Full Text] [Related]
17. HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2. Ye Y; Yang S; Han Y; Sun J; Xv L; Wu L; Ming L Open Biol; 2019 Sep; 9(9):190068. PubMed ID: 31551012 [TBL] [Abstract][Full Text] [Related]
18. LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis. Shao S; Wang C; Wang S; Zhang H; Zhang Y Biomed Pharmacother; 2019 Sep; 117():109082. PubMed ID: 31212131 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression. Shi L; Hong X; Ba L; He X; Xiong Y; Ding Q; Yang S; Peng G Cell Death Dis; 2019 Feb; 10(3):150. PubMed ID: 30770796 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway. Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]